TY  - GEN
AU  - Sugimoto,T
AU  - Das,H
AU  - Imoto,S
AU  - Murayama,T
AU  - Gomyo,H
AU  - Chakraborty,S
AU  - Taniguchi,R
AU  - Isobe,T
AU  - Nakagawa,T
AU  - Nishimura,R
AU  - Koizumi,T
TI  - Quantitation of minimal residual disease in t(8;21)-positive acute myelogenous leukemia patients using real-time quantitative RT-PCR
SN  - 0361-8609
PY  - 2000///0621
KW  - Adult
KW  - Antineoplastic Agents
KW  - therapeutic use
KW  - Bone Marrow Transplantation
KW  - Chromosomes, Human, Pair 21
KW  - Chromosomes, Human, Pair 8
KW  - Combined Modality Therapy
KW  - Computer Systems
KW  - Core Binding Factor Alpha 2 Subunit
KW  - Female
KW  - Humans
KW  - Leukemia, Myeloid, Acute
KW  - diagnosis
KW  - Male
KW  - Middle Aged
KW  - Neoplasm, Residual
KW  - Oncogene Proteins, Fusion
KW  - genetics
KW  - RNA, Messenger
KW  - analysis
KW  - RUNX1 Translocation Partner 1 Protein
KW  - Reverse Transcriptase Polymerase Chain Reaction
KW  - Sensitivity and Specificity
KW  - Transcription Factors
KW  - Translocation, Genetic
KW  - Transplantation, Homologous
N1  - Publication Type: Journal Article
UR  - https://doi.org/10.1002/(sici)1096-8652(200006)64:2<101::aid-ajh5>3.0.co;2-x
ER  -